Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$43.66 - $61.0 $12,923 - $18,056
296 Added 2.07%
14,580 $785,000
Q2 2022

Aug 08, 2022

SELL
$28.82 - $77.35 $78,937 - $211,861
-2,739 Reduced 16.09%
14,284 $576,000
Q1 2022

May 13, 2022

SELL
$48.25 - $100.49 $62,146 - $129,431
-1,288 Reduced 7.03%
17,023 $1.13 Million
Q4 2021

Feb 09, 2022

BUY
$88.71 - $120.43 $798 - $1,083
9 Added 0.05%
18,311 $1.83 Million
Q3 2021

Nov 12, 2021

BUY
$98.77 - $132.17 $38,322 - $51,281
388 Added 2.17%
18,302 $2.29 Million
Q2 2021

Aug 11, 2021

SELL
$109.77 - $165.68 $548 - $828
-5 Reduced 0.03%
17,914 $2.23 Million
Q1 2021

May 13, 2021

BUY
$127.04 - $179.1 $40,017 - $56,416
315 Added 1.79%
17,919 $2.74 Million
Q4 2020

Feb 11, 2021

BUY
$99.96 - $135.93 $1,099 - $1,495
11 Added 0.06%
17,604 $2.27 Million
Q3 2020

Nov 12, 2020

SELL
$80.32 - $111.8 $403,768 - $562,018
-5,027 Reduced 22.22%
17,593 $1.97 Million
Q2 2020

Oct 22, 2020

SELL
$60.49 - $97.5 $396,390 - $638,917
-6,553 Reduced 22.46%
22,620 $1.84 Million
Q2 2020

Aug 14, 2020

BUY
$60.49 - $97.5 $721,101 - $1.16 Million
11,921 Added 69.1%
29,173 $2.3 Million
Q1 2020

May 14, 2020

SELL
$59.04 - $88.81 $431,759 - $649,467
-7,313 Reduced 29.77%
17,252 $1.2 Million
Q4 2019

Feb 14, 2020

SELL
$59.49 - $82.78 $2,855 - $3,973
-48 Reduced 0.2%
24,565 $1.92 Million
Q3 2019

Nov 14, 2019

BUY
$62.59 - $110.3 $423,108 - $745,628
6,760 Added 37.86%
24,613 $1.57 Million
Q2 2019

Aug 14, 2019

SELL
$63.94 - $91.11 $218,163 - $310,867
-3,412 Reduced 16.05%
17,853 $1.54 Million
Q1 2019

May 14, 2019

SELL
$34.3 - $97.98 $168,138 - $480,297
-4,902 Reduced 18.73%
21,265 $1.63 Million
Q4 2018

Feb 14, 2019

BUY
$29.2 - $46.1 $764,076 - $1.21 Million
26,167 New
26,167 $984,000

Others Institutions Holding GH

About Guardant Health, Inc.


  • Ticker GH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,220,000
  • Market Cap $3.34B
  • Description
  • Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...
More about GH
Track This Portfolio

Track Baird Financial Group, Inc. Portfolio

Follow Baird Financial Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baird Financial Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Baird Financial Group, Inc. with notifications on news.